S&P 및 Nasdaq 내재가치 문의하기

MedTech Acquisition Corporation MTAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 33 건의 최근 내부자 거래 내역가 기록되었습니다 MedTech Acquisition Corporation (MTAC), 포함 14 건 매수14 건 매도. 내부자 매수 총액은 $9.01M 내부자 매도 총액은 $5.27M.

최근 활동이 있는 주요 내부자에는 Devlin Jodi, Szela Mary T, Murphy Sean. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — MTAC

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2023-08-30 Devlin Jodi President, Therapeutics RSU 부여 195,000 $6.70 $1.31M 195,000
2023-08-28 Devlin Jodi Officer 알 수 없음 - - - -
2023-08-14 Szela Mary T CEO and President RSU 부여 172,500 $11.51 $1.99M 172,500
2023-08-11 Murphy Sean Chief Financial Officer RSU 부여 62,500 $12.00 $750K 62,500
2023-08-11 Cox Bryan F. Chief Scientific & Manufact. RSU 부여 40,000 $12.00 $480K 40,000
2023-08-11 Stevens Jennifer Chief Regulatory Officer RSU 부여 40,000 $12.00 $480K 40,000
2023-08-11 Marshak Richard Sr.vp, Corp. Dev. & Strategy RSU 부여 40,000 $12.00 $480K 40,000
2023-08-11 Katz Steven C Chief Medical Officer RSU 부여 62,500 $12.00 $750K 62,500
2023-08-10 Hicks Kerry R Director 처분 4,943 $2.43 $12.01K -
2023-08-10 Hicks Kerry R Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Matlin David J Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Wahlstrom Mats 10 Percent Owner 알 수 없음 50,000 $10.00 $500K -
2023-08-10 Wahlstrom Mats 10 Percent Owner RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Von Eschenbach Andrew C. Director 알 수 없음 - - - -
2023-08-10 Von Eschenbach Andrew C. Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Murphy Sean Chief Financial Officer 처분 31,287 $10.30 $322.26K -
2023-08-10 Alecxih James President, Device Technology 처분 94,754 $10.30 $975.97K -
2023-08-10 Cox Bryan F. Chief Scientific & Manufact. 처분 8,391 $10.30 $86.43K -
2023-08-10 Martin George Kelly Director 알 수 없음 - - - -
2023-08-10 Martin George Kelly Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Stevens Jennifer Chief Regulatory Officer 처분 8,391 $10.30 $86.43K -
2023-08-10 Marshak Richard Sr.vp, Corp. Dev. & Strategy 처분 8,391 $10.30 $86.43K -
2023-08-10 Singhal Anil K. Director 처분 12,359 $2.43 $30.03K -
2023-08-10 Singhal Anil K. Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Desai Arjun Jj Director 처분 - - - 203,127
2023-08-10 Desai Arjun Jj Director RSU 부여 35,000 $11.34 $396.9K 35,000
2023-08-10 Katz Steven C Chief Medical Officer 처분 31,040 $10.30 $319.71K -
2023-08-10 Frankenius Equity Ab 10 Percent Owner 처분 230,000 $10.00 $2.3M -
2023-08-10 Szela Mary T CEO and President 처분 58,409 $10.30 $601.61K -
2023-06-26 Medtech Acquisition Sponsor Llc 10 Percent Owner 전환 (매도) 6,249,999 - - 1
2023-06-12 Magnetar Financial Llc 10 Percent Owner 기타 (매도) 42,567 $10.49 $446.36K -
2022-12-12 Magnetar Financial Llc Director 알 수 없음 - - - 21,780
2020-12-17 Desai Arjun Jj Director 처분 246,667 - - -
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기